Promoting Benzodiazepine Cessation Through an Electronically-delivered Patient Self-management Intervention
Key facts
- Who runs it
- VA Office of Research and Development
- Where
- Palo Alto, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 170 people enrolled
- Started
- 1 Jun 2022
- Ended
- 3 Jul 2024
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- EMPOWER-ED
- Record updated
- 23 January 2026
Who can take part
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- Veterans having a VA primary care provider and taking prescribed benzodiazepines for at least 3 months
- Have access to a smartphone, tablet, or computer
Who cannot take part
- Individuals receiving palliative care
- Individuals diagnosed with schizophrenia, dementia, seizure disorder, and/or spinal cord injury
Where in United States
- VA Palo Alto Health Care System, Palo Alto, CAPalo Alto, United States
About the trial
What the trial wants to find out
Benzodiazepines (e.g., Ativan, Xanax) are widely prescribed medications that are used mainly to treat anxiety and sleeping difficulties. Long-term use of benzodiazepine carries risks of physical dependence, addiction, falls and other accidents, and problems in thinking/concentrating. Researchers in Canada developed a printed self-help packet that enabled many individuals to reduce or cease taking benzodiazepines on their own. This study is designed to tailor that packet to the Veteran population, convert it to an app that people can use on their laptop or smart phone, and test whether the app helps promote benzodiazepine prescribing.
The 2 groups in the trial
- EMPOWER-EDTreatment being tested
Individuals will be given access on their preferred platform to an electronic self-help app focused on reducing benzodiazepine use
- ControlNo study treatment, for comparison
Individuals will be provided care as usual
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 23 January 2026